Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S Banditelli is active.

Publication


Featured researches published by S Banditelli.


Chemico-Biological Interactions | 2001

Modulation of aldose reductase activity through S-thiolation by physiological thiols.

Mario Cappiello; Pietro Amodeo; Blanca López Méndez; Andrea Scaloni; Pier Giuseppe Vilardo; I Cecconi; Massimo Dal Monte; S Banditelli; Fabio Talamo; Vanna Micheli; Frank J. Giblin; Antonella Del Corso; Umberto Mura

The glutathionyl-modified aldose reductase (GS-ALR2) is unique, among different S-thiolated enzyme forms, in that it displays a lower specific activity than the native enzyme (ALR2). Specific interactions of the bound glutathionyl moiety (GS) with the ALR2 active site, were predicted by a low perturbative molecular modelling approach. The outcoming GS allocation, involving interactions with residues relevant for catalysis and substrate allocation, explains the rationale behind the observed differences in the activity between GS-ALR2 and other thiol-modified enzyme forms. The reversible S-glutathionylation of ALR2 observed in cultured intact bovine lens undergoing an oxidative/non oxidative treatment cycle is discussed in terms of the potential of ALR2/GS-ALR2 inter-conversion as a response to oxidative stress conditions.


International Journal of Cancer | 1998

Deoxyadenosine metabolism in a human colon-carcinoma cell line (LoVo) in relation to its cytotoxic effect in combination with deoxycoformycin

Valentina Bemi; Nicola Tazzini; S Banditelli; Francesco Giorgelli; Rossana Pesi; Gino Turchi; Antonella Mattana; Francesco Sgarrella; Maria Grazia Tozzi; Marcella Camici

We have assessed the intracellular metabolism of 2′‐deoxyadenosine in a human colon‐carcinoma cell line (LoVo), both in the absence and in the presence of deoxycoformycin, the powerful inhibitor of adenosine deaminase. The combination of 2′‐deoxyadenosine and deoxycoformycin has been reported to inhibit the growth of LoVo cells in culture. In this paper we demonstrate that the observed toxic effect is strictly dependent on cell density. In the absence of deoxycoformycin, 2′‐deoxyadenosine is primarily deaminated to 2′‐deoxyinosine and then converted into hypoxanthine. In the presence of the inhibitor, the deoxynucleoside, in addition to a phosphorylation process, undergoes phosphorolytic cleavage giving rise to adenine. The conversion of 2′‐deoxyadenosine to adenine might represent a protective device, emerging when the activity of adenosine deaminase is reduced or inhibited. There is much evidence to indicate that the enzyme catalyzing this process may be distinct from methylthioadenosine phosphorylase and S‐adenosyl homocysteine hydrolase, which are the enzymes reported to be responsible for the formation of adenine from 2′‐deoxyadenosine in mammals. Int. J. Cancer 75:713–720, 1998.© 1998 Wiley‐Liss, Inc.


Advances in Experimental Medicine and Biology | 1999

Interconversion pathways of aldose reductase induced by thiol compounds.

Antonella Del Corso; Pier Giuseppe Vilardo; Catia Barsotti; Mario Cappiello; I Cecconi; Massimo Dal Monte; I Marini; S Banditelli; Umberto Mura

The occurrence of protein S-thiolation as a consequence of oxidative stress is widely recognized (Thomas et al., 1990; Lou et at, 1990; Schuppe et al., 1992; Giblin, et al., 1995). However, the role and the relevance of this process are still a matter of debate.


Archives of Biochemistry and Biophysics | 1998

SITE-SPECIFIC INACTIVATION OF ALDOSE REDUCTASE BY 4-HYDROXYNONENAL

Antonella Del Corso; Massimo Dal Monte; Pier Giuseppe Vilardo; I Cecconi; Roberta Moschini; S Banditelli; Mario Cappiello; L. Tsai; Umberto Mura


The International Journal of Biochemistry & Cell Biology | 1996

The phosphotransferase activity of cytosolic 5′-nucleotidase; a purine analog phosphorylating enzyme

S Banditelli; Cristina Baiocchi; Rossana Pesi; S. Allegrini; Maura Turriani; Piero Luigi Ipata; Marcella Camici; Maria Grazia Tozzi


Experimental Eye Research | 1999

A new approach against sugar cataract through aldose reductase inhibitors.

S Banditelli; Enrico Boldrini; Pier Giuseppe Vilardo; I Cecconi; Mario Cappiello; Massimo Dal Monte; I Marini; Antonella Del Corso; Umberto Mura


Experimental Eye Research | 2000

Thiol-disulfide exchange modulates the activity of aldose reductase in intact bovine lens as a response to oxidative stress

Mario Cappiello; Pier Giuseppe Vilardo; Vanna Micheli; Gabriella Jacomelli; S Banditelli; Victor R. Leverenz; Frank J. Giblin; Antonella Del Corso; Umberto Mura


Investigative Ophthalmology & Visual Science | 2001

Cysteinylglycine hydrolase activity in bovine lens

Umberto Mura; Mario Cappiello; I Cecconi; F Buono; M Dal Monte; S Banditelli; Roberta Moschini; I Marini; A Del Corso


Experimental Eye Research | 2000

The antioxidant/prooxidant action of physiological thiols in promoting protein S-thiolation processes

Umberto Mura; Mario Cappiello; I Cecconi; Pg Vilardo; S Banditelli; Massimo Dal Monte; Antonella Del Corso


45° Congresso Nazionale SIB | 2000

The aldose reductase inhibitor ARI509 as a potentially effective drug for a long term cyclic therapy against diabetic cataract

S Banditelli; Enrico Boldrini; I Cecconi; Roberta Moschini; F Buono; Catia Barsotti; Massimo Dal Monte; Mario Cappiello; Antonella Del Corso; Umberto Mura

Collaboration


Dive into the S Banditelli's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge